)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
Pacira BioSciences (PCRX) investor relations material
Pacira BioSciences Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary6 Nov, 2025
Executive summary
Achieved 6% year-over-year revenue growth in Q3 2025, driven by strong EXPAREL and iovera° performance, with ZILRETTA showing modest growth and veterinary product sales fluctuating due to order timing.
Treated over 3 million patients annually, focusing on musculoskeletal pain and adjacent markets, while transitioning to an innovative biopharmaceutical organization.
Expanded clinical pipeline with in-licensing of AMT-143, a long-acting non-opioid pain therapy, and completed the acquisition of GQ Bio Therapeutics.
Strengthened intellectual property with the 21st EXPAREL patent listed in the FDA Orange Book, extending exclusivity to July 2044.
Implemented cost-saving measures, including workforce reduction and decommissioning a manufacturing suite, resulting in $3.7 million in restructuring charges and anticipated $13 million in annual savings.
Financial highlights
Q3 2025 net product sales reached $179.5 million, with EXPAREL at $139.9 million, ZILRETTA at $29.0 million, and iovera° at $6.5 million.
Gross margin improved to 82% non-GAAP (81% GAAP), up from 78% prior year, driven by manufacturing efficiencies and lower inventory reserves.
Adjusted EBITDA for Q3 2025 was $49.4 million.
Net income for Q3 2025 was $5.4 million ($0.12 per share), compared to a net loss in Q3 2024.
Ended Q3 2025 with $246.3 million in cash and investments.
Outlook and guidance
Full-year 2025 revenue guidance narrowed to $725–$735 million, with non-GAAP gross margin guidance raised to 80–82% (from 78–80%).
Non-GAAP R&D expense expected at $95–$105 million; SG&A at $310–$320 million.
Management targets double-digit compounded annual product revenue growth through 2030 and expects annual operating expense reduction of $13 million from restructuring.
Anticipates reporting interim results from the Phase 2 ASCEND study of PCRX-201 for knee osteoarthritis before the end of 2026.
Sufficient liquidity to fund operations and capital needs for at least the next 12 months.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Pacira BioSciences earnings date
Q4 202526 Feb, 2026
Next Pacira BioSciences earnings date
Q4 202526 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Pacira BioSciences Inc. is a pharmaceutical company focused on developing and commercializing non-opioid pain management and regenerative health solutions. The company's primary offerings include products designed to provide long-lasting pain relief for patients undergoing surgical procedures. Pacira BioSciences serves the healthcare sector, working with hospitals, ambulatory surgery centers, and healthcare providers to reduce reliance on opioids and improve patient outcomes through its innovative treatments. The company is headquartered in Tampa, Florida, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage